儿童再生障碍性贫血诊疗规范(2019年版)

2019-09-05 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童再生障碍性贫血诊疗规范(2019年版)。

中文标题:

儿童再生障碍性贫血诊疗规范(2019年版)

发布日期:

2019-09-05

简要介绍:

为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童再生障碍性贫血诊疗规范(2019年版)。

 

拓展指南:再生障碍性贫血相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童再生障碍性贫血诊疗规范(2019年版))] GetToolGuiderByIdResponse(projectId=1, id=c0e9d1c001e921c0, title=儿童再生障碍性贫血诊疗规范(2019年版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童再生障碍性贫血诊疗规范(2019年版)。 , cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童再生障碍性贫血诊疗规范(2019年版)。 </P> <P> </P>拓展指南:<strong>与<font color=red>再生障碍性贫血</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=447341c001518e4c" title="再生障碍性贫血诊断与治疗中国专家共识(2017版)解读" target=_blank>再生障碍性贫血诊断与治疗中国专家共识(2017版)解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fe6eb1c001368004" title="再生障碍性贫血诊断与治疗中国专家共识(2017年版)" target=_blank>再生障碍性贫血诊断与治疗中国专家共识(2017年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=e10d01c00118900f" title="2015 BCSH指南:成人再生障碍性贫血的诊断和管理" target=_blank>2015 BCSH指南:成人再生障碍性贫血的诊断和管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4ec031c0010ae0d6" title="2014 儿童获得性再生障碍性贫血诊疗建议" target=_blank>2014 儿童获得性再生障碍性贫血诊疗建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3221a1c000e9683c" title="再生障碍性贫血诊断治疗专家共识(2010)" target=_blank>再生障碍性贫血诊断治疗专家共识(2010)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%86%8D%E7%94%9F%E9%9A%9C%E7%A2%8D%E6%80%A7%E8%B4%AB%E8%A1%80" target=_blank>有关再生障碍性贫血更多指南</a></ul>, tagList=[TagDto(tagId=94544, tagName=儿童再生障碍性贫血)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8544, appHits=575, showAppHits=0, pcHits=3947, showPcHits=5190, likes=51, shares=30, comments=17, approvalStatus=1, publishedTime=Mon Sep 16 23:38:45 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Sep 16 23:38:45 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:07:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童再生障碍性贫血诊疗规范(2019年版))])
儿童再生障碍性贫血诊疗规范(2019年版)
下载请点击:
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=965028, encodeId=9617965028b1, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/5e121301999749fc8ce4e5983dab9c76/5d2a1a5f5ab84679abfefca066ac4d59.jpg, createdBy=733f5453289, createdName=ms7000000461816055, createdTime=Wed May 12 21:19:08 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925757, encodeId=5e9e925e5784, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:24:31 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925755, encodeId=4516925e55c9, content=学习吸收, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:21:54 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925753, encodeId=56f6925e5353, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:26 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925752, encodeId=8721925e52b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:08 CST 2021, time=2021-02-20, status=1, ipAttribution=)]
    2021-05-12 ms7000000461816055

    优秀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=965028, encodeId=9617965028b1, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/5e121301999749fc8ce4e5983dab9c76/5d2a1a5f5ab84679abfefca066ac4d59.jpg, createdBy=733f5453289, createdName=ms7000000461816055, createdTime=Wed May 12 21:19:08 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925757, encodeId=5e9e925e5784, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:24:31 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925755, encodeId=4516925e55c9, content=学习吸收, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:21:54 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925753, encodeId=56f6925e5353, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:26 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925752, encodeId=8721925e52b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:08 CST 2021, time=2021-02-20, status=1, ipAttribution=)]
    2021-02-20 wxt0426

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=965028, encodeId=9617965028b1, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/5e121301999749fc8ce4e5983dab9c76/5d2a1a5f5ab84679abfefca066ac4d59.jpg, createdBy=733f5453289, createdName=ms7000000461816055, createdTime=Wed May 12 21:19:08 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925757, encodeId=5e9e925e5784, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:24:31 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925755, encodeId=4516925e55c9, content=学习吸收, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:21:54 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925753, encodeId=56f6925e5353, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:26 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925752, encodeId=8721925e52b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:08 CST 2021, time=2021-02-20, status=1, ipAttribution=)]
    2021-02-20 wxt0426

    学习吸收

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=965028, encodeId=9617965028b1, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/5e121301999749fc8ce4e5983dab9c76/5d2a1a5f5ab84679abfefca066ac4d59.jpg, createdBy=733f5453289, createdName=ms7000000461816055, createdTime=Wed May 12 21:19:08 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925757, encodeId=5e9e925e5784, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:24:31 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925755, encodeId=4516925e55c9, content=学习吸收, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:21:54 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925753, encodeId=56f6925e5353, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:26 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925752, encodeId=8721925e52b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:08 CST 2021, time=2021-02-20, status=1, ipAttribution=)]
    2021-02-20 wxt0426

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=965028, encodeId=9617965028b1, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/5e121301999749fc8ce4e5983dab9c76/5d2a1a5f5ab84679abfefca066ac4d59.jpg, createdBy=733f5453289, createdName=ms7000000461816055, createdTime=Wed May 12 21:19:08 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925757, encodeId=5e9e925e5784, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:24:31 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925755, encodeId=4516925e55c9, content=学习吸收, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:21:54 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925753, encodeId=56f6925e5353, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:26 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925752, encodeId=8721925e52b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Sat Feb 20 10:20:08 CST 2021, time=2021-02-20, status=1, ipAttribution=)]
    2021-02-20 wxt0426

    谢谢

    0